Natco Pharma names Imtiyaz Basade as Senior Vice President - RAD, Pharma Division, Kothur Unit
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-11-05 05:54 GMT | Update On 2024-11-05 05:54 GMT
Advertisement
Telangana: Natco Pharma has announced that Imtiyaz Basade has been appointed as Senior Vice President - RAD, Pharma Division, Kothur Unit w.e.f. 4th November, 2024.
Imtiyaz Basade has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends. He was involved in planning and implementation of activities related to mergers and demergers, product acquisitions and divestments. He was also involved in policy framing of the new regulations with aid of industry associations, secretaries of respective ministries and Indian FDA. His managerial competencies are planning, communication and implementation skills, foresight and strategic thinking, system orientation and leadership skills. He has attended international meetings with various agencies like, EDQM, MoH of South Africa, Morocco, Zimbabwe, Kenya, Thailand, Malaysia, WHO Geneva.
Prior to joining with NATCO Pharma Limited Imtiyaz Basade worked with Mylan Laboratories Limited, Orchid Chemicals & Pharmaceuticals Ltd., Wockhardt Limited, Ranbaxy Laboratories Ltd., Dr Reddy's Laboratories Ltd., Lupin Laboratories Ltd., Fulford (India) Ltd., and Pfizer Ltd. He did Master’s in Pharmacy from University Department of Chemical Technology, Bombay University.
Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with modern research laboratories, capabilities in New Drug Development, etc.
Read also: NATCO Pharma Canada arm invests over Rs 67 crore in biotech company eGenesis
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.